StockData
Bicycle Therapeutics PLC logo

Bicycle Therapeutics PLC (BCYC) bonds

BCYCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 11/3080% below fair value
$3.20+0.02 (+0.63%)

Close on Nov 17, 2026Market cap $224.30MP/E –Yield 0.00%

Debt

Borrowings on the balance sheet, Sep 30, 2026

Bicycle Therapeutics reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

When the debt comes due

Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2022

From the debt maturity table in the annual report (filing). “Later” is everything due after year five.

Notes and loans outstanding

As tagged in Bicycle Therapeutics's 10-K for the period ended Jul 15, 2022

IssueCoupon
Second Amendment to LSA8.05%

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-K.

Credit facilities

Revolving credit lines and other committed borrowing capacity

FacilitySize
Term Loan$75.00M

See a number that looks wrong?